QQ客服 官方微博 反馈留言

	Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials
	Zhang, Yiliang; Sun, Yihua; Wang, Lei; Ye, Ting; Pan, Yunjian; Hu, Haichuan; Yu, Yongfu; Zhao, Naiqing; Song, Yanyan; Garfield, David
刊名	ONCOTARGETS AND THERAPY
	2013
卷号	6
关键词	EGFR mutation tyrosine kinase inhibitor chemotherapy non-small cell lung cancer clinical trial
ISSN号	1178-6930
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4893023
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhang, Yiliang,Sun, Yihua,Wang, Lei,et al. Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials[J]. ONCOTARGETS AND THERAPY,2013,6.
APA	Zhang, Yiliang.,Sun, Yihua.,Wang, Lei.,Ye, Ting.,Pan, Yunjian.,...&Chen, Haiquan.(2013).Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials.ONCOTARGETS AND THERAPY,6.
MLA	Zhang, Yiliang,et al."Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials".ONCOTARGETS AND THERAPY 6(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。